Gut microbiota dysbiosis affects almost all human diseases. Current diagnosis approaches are slow, expensive, inconvenient and invasive. This invention relates to the first in the world discovery to simultaneously detect the risk for multiple diseases using fecal microbiome-based multi-class machine learning. This offers a simple non-invasive "one-stop" test for early detection of multiple diseases.
In recent years, the incidence of many diseases has been rising. The key to any disease treatment is early detection, early diagnosis and early treatment. Traditional medical tests are expensive and invasive.
First Asia-based, leading International Microbiome Innovation Centre.
Pioneering microbiome research leading to scientific discoveries and clinical applications of gut microbiota has set foot in the newly founded Microbiota I-Center (MagIC) in Hong Kong. Together with top-notch researchers, the center will focus on utilizing the human gut microbiome for the development of novel microbial biomarkers and personalized microbiome therapeutics. This approach sets a new frontier for the pharmaceutical, healthcare, and food industries in Hong Kong.